Herein described are solid compositions for the oral administration of dyes and diagnostic use thereof. Preferably such diagnostic use is aimed at the diagnostic evaluation of the gastrointestinal tract.
The present disclosure relates to an (in situ gelling) enema containing Rifamycin SV and its use in the treatment of pouchitis, proctitis and/or distal ulcerative colitis (including proctosigmoiditis). More particularly, the present disclosure describes an in situ gelling retentive enema containing Rifamycin SV for ...
Documents
Optional Attachment-(1)-30102022
-30102022
Form INC-20A-30102022
Directors report as per section 134(3)-30102022
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-30102022